Extracorporeal shock wave therapy in the management of insertional plantar fasciitis: The ASSERT database
Articolo
Data di Pubblicazione:
2018
Abstract:
Introduction: To determine the effectiveness of ESWT in patients suffering from plantar fasciitis in both the short and long term.
Methods: Participants were enrolled by different clinicians in the National Health Service (NHS) and private sector centres in the United Kingdom.
Data were collected in a web-based database [Assessment of the Effectiveness of Extracorporeal Shock Wave Therapy (ESWT) For Soft Tissue Injuries (ASSERT)]. The 198 participants (mean age 48.17 y; range 20-82 y) were treated using a standardized
ESWT protocol, and different outcome measures relative to their specific condition and health status [Visual Analogue Scale (VAS) for pain perception, the Foot Function Index (FFI) for limitations in everyday life activities, and the 6 scores of EuroQol-5D questionnaire (EQ-5D) for quality of life] were assessed at baseline, and 3, 6, 12 and 24 months following ESWT treatment.
Results: There was a significant improvement over time in 6 of the 8 analysed scores (all with p<0.0001) [VAS, FFI, and 4 scores of EQ-5D (Mobility, Pain/Discomfort, Usual Activities, and Thermometer Scale)].
Conclusion: ESWT exerts beneficial effects on PF over a 24-month follow-up period. Level of evidence: IV.
Methods: Participants were enrolled by different clinicians in the National Health Service (NHS) and private sector centres in the United Kingdom.
Data were collected in a web-based database [Assessment of the Effectiveness of Extracorporeal Shock Wave Therapy (ESWT) For Soft Tissue Injuries (ASSERT)]. The 198 participants (mean age 48.17 y; range 20-82 y) were treated using a standardized
ESWT protocol, and different outcome measures relative to their specific condition and health status [Visual Analogue Scale (VAS) for pain perception, the Foot Function Index (FFI) for limitations in everyday life activities, and the 6 scores of EuroQol-5D questionnaire (EQ-5D) for quality of life] were assessed at baseline, and 3, 6, 12 and 24 months following ESWT treatment.
Results: There was a significant improvement over time in 6 of the 8 analysed scores (all with p<0.0001) [VAS, FFI, and 4 scores of EQ-5D (Mobility, Pain/Discomfort, Usual Activities, and Thermometer Scale)].
Conclusion: ESWT exerts beneficial effects on PF over a 24-month follow-up period. Level of evidence: IV.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Maffulli, G.; Padulo, J.; Iuliano, E.; Saxena, A.; Rompe, J.; Maffulli, N.
Link alla scheda completa:
Pubblicato in: